Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · IEX Real-Time Price · USD
8.00
-0.08 (-0.99%)
At close: Jun 18, 2024, 4:00 PM
7.98
-0.02 (-0.25%)
After-hours: Jun 18, 2024, 7:59 PM EDT

Iovance Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018 - 2007
Net Income
-444.04-395.89-342.25-259.58-197.56
Upgrade
Depreciation & Amortization
33.1321.1413.988.718.12
Upgrade
Share-Based Compensation
62.6384.0269.7740.8924.28
Upgrade
Other Operating Activities
-13.54-2.0230.574.856.27
Upgrade
Operating Cash Flow
-361.82-292.76-227.94-205.13-158.89
Upgrade
Capital Expenditures
-22.29-20.43-37.57-46.79-6.92
Upgrade
Acquisitions
-212.630000
Upgrade
Change in Investments
79.68276.8837.71-271.0696.94
Upgrade
Investing Cash Flow
-155.24256.460.13-317.8590.03
Upgrade
Share Issuance / Repurchase
465.75192.8238.27576.716.44
Upgrade
Debt Issued / Paid
00100
Upgrade
Other Financing Activities
-2.8-2.65--0.28-0.31
Upgrade
Financing Cash Flow
462.96190.15239.27576.426.13
Upgrade
Exchange Rate Effect
-2.740000
Upgrade
Net Cash Flow
-56.84153.8511.4653.44-62.73
Upgrade
Free Cash Flow
-384.11-313.18-265.52-251.93-165.81
Upgrade
Free Cash Flow Margin
-32305.30%----
Upgrade
Free Cash Flow Per Share
-1.63-1.97-1.73-1.82-1.33
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).